Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Progressive IgA Nephropathy
NCT00498368Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2009
- Primary completion
- Sep 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in IgA nephropathy (IgAN), sponsored by Mayo Clinic. Started Feb 2009; status: completed.
02
Drugs
rituximab
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00498368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498368.